In addition to p-tau, beta amyloid proteins in the blood, particularly the ratio of beta amyloid 42 to beta amyloid 40 (Aβ42/Aβ40), also correlates with an increased risk of dementia and AD progression [9,10,11]. This evidence concerns the gene MAPT and Alzheimer disease.